CD34+ pigmented fibrous proliferations: The morphologic overlap between pigmented dermatofibromas and bednar tumors

American Journal of Dermatopathology

Volumn 30, Issue 5, 2008, Pages 484-487

  McAllister, Josephine C ^a,c   Recht, Bernard ^b   Hoffman, Thomas E ^b   Sundram, Uma N ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bednar tumor; Dermatofi brosarcoma protuberans; Dermatofibroma; Melanocytic; Pigment

Indexed keywords

CD34 ANTIGEN; COLLAGEN FIBER;

ADULT; ARTICLE; BASAL CELL; CANCER SURGERY; CASE REPORT; CELL PROLIFERATION; CLINICAL EXAMINATION; DENDRITE; FEMALE; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MELANOCYTE; MORPHOLOGY; OUTCOME ASSESSMENT; PIGMENT DISORDER; PIGMENTED FIBROUS LESION; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN EXAMINATION; SPINDLE CELL; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; DERMIS; DIFFERENTIAL DIAGNOSIS; METABOLISM; PATHOLOGY; SKIN PIGMENTATION;

ADULT; ANTIGENS, CD34; CELL PROLIFERATION; DERMATOFIBROSARCOMA; DERMIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; MALE; MELANOCYTES; SKIN PIGMENTATION;

EID: 58149312892     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181723666     Document Type: Article

References (20)

1. Kempson RL, Fletcher CDM, Evans HL, et al. Fibrous histiocytomas. In: Atlas of Tumor Pathology: Tumors of the Soft Tissues. Bethesda, MD: Armed Forces Institute of Pathology; 2001:113-186.
2. Cerio R, Griffiths CEM, Cooper KD, et al. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol. 1989;121:421-431.
3. Altman DA, Nickoloff BJ, Fivenson DP. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. J Cutan Pathol. 1993; 20:154-158.
4. Fletcher CDM, Evans BJ, MacArtney JC, et al. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology. 1985;9:921-938.
5. Aiba S, Tabata N, Ishii H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br J Dermatol. 1992;127: 79-84.
6. Kitzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol. 1993;28:613-617.
7. Zelger B, Sidoroff A, Stanzl U, et al. Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. Am J Surg Pathol. 1994;18: 677-686.
8. Wang J, Hisaoka M, Shimajiri S, et al. Detection of COLIAI-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin embedded tissues. J Mol Diagn. 1999;8:113-119.
9. Nakamura T, Ogata H, Katsuyama T. Pigmented dermatofibrosarcoma protuberans. Am J Dermatopathol. 1987;9:18-25.
10. Lopez JI, Elizalde JM, Fernandez-Larrinoa A. Pigmented dermatofibrosarcoma protuberans (Bednar tumor). Dermatology. 1992;184:281-282.
11. Kagoura M, Toyoda M, Nagahori H, et al. An ultrastructural and immunohistochemical study of pigmented dermatofibrosarcoma protuberans (Bednar tumor). Eur J Dermatol. 1999;9:366-369.
12. King R, Googe PB, Page RN, et al. Melanocytic lesions associated with dermatofibromas: a spectrum of lesions ranging from junctional nevus to malignant melanoma in situ. Mod Pathol. 2005;18:1043-1047.
13. Sachdev R, Sundram U. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa. J Cutan Pathol. 2006;33:353-360.
14. Diaz-Cascajo C, Borghi S, Bonczkowitz M. Pigmented atypical fibroxanthoma. Histopathology. 1998;33:537-541.
15. Diaz-Cascajo C, Weyers W, Borghi S. Pigmented atypical fibroxanthoma: a tumor that may be easily mistaken for malignant melanoma. Am J Dermatopathol. 2003;25:1-5.
16. Zelger B. Pigmented atypical fibroxanthoma, a dermatofibroma variant? Am J Dermatopathol. 2004;26:84-86.
17. Horenstein MG, Prieto VG, Nuckols JD, et al. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans? Am J Surg Pathol. 2000;24:996-1003.
18. Wick MR, Ritter JH, Lind AC, et al. The pathological distinction between "deep penetrating" dermatofibroma and dermatofibrosarcoma protuberans. Semin Cutan Med Surg. 1999;18:91-98.
19. Kamino H, Jacobson M. Dermatofibroma extending into the subcutaneous tissue: differential diagnosis from dermatofibrosarcoma protuberans. Am J Surg Pathol. 1990;14:1156-1164.
20. Patel KU, Szabo SS, Hernandez VS, et al. Dermatofibrosarcoma protuberans COLIAI-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum. Pathol. 2008 Feb; 39(2): 184-193. and POGFR-A.